VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $236,000 | -83.0% | 10,000 | -81.8% | 0.02% | -77.9% |
Q3 2016 | $1,385,000 | +24.2% | 55,000 | 0.0% | 0.07% | -32.7% |
Q2 2016 | $1,115,000 | -85.5% | 55,000 | -25.7% | 0.10% | -73.8% |
Q4 2015 | $7,692,000 | -39.6% | 74,000 | +0.3% | 0.38% | -43.5% |
Q3 2015 | $12,732,000 | -16.7% | 73,800 | +6.6% | 0.68% | -13.2% |
Q2 2015 | $15,285,000 | +10.1% | 69,200 | 0.0% | 0.79% | +18.4% |
Q1 2015 | $13,879,000 | -21.8% | 69,200 | -44.6% | 0.66% | -17.3% |
Q4 2014 | $17,739,000 | +8.6% | 125,000 | 0.0% | 0.80% | +6.5% |
Q3 2014 | $16,333,000 | +14.2% | 125,000 | +10.6% | 0.75% | +20.8% |
Q2 2014 | $14,299,000 | +19.2% | 113,000 | +22.2% | 0.62% | -29.7% |
Q1 2014 | $11,998,000 | +25.8% | 92,500 | +12.8% | 0.89% | +58.3% |
Q4 2013 | $9,536,000 | +10.9% | 82,000 | 0.0% | 0.56% | -7.0% |
Q3 2013 | $8,597,000 | +23.4% | 82,000 | +12.3% | 0.60% | +14.9% |
Q2 2013 | $6,967,000 | – | 73,000 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |